Cannabis Strain Names Often Outrun the Genetics Behind Them

Labels such as “Sativa,” “Indica,” “Hybrid” and individual strain names are widely used to describe cannabis products. But a 2019 genetic study found that these labels do not always correspond to consistent underlying DNA—and that products sold under the same name may not be closely related.

Researchers Anna L. Schwabe and Mitchell E. McGlaughlin of the University of Northern Colorado analyzed 122 cannabis samples representing 30 strain names. The study, published in the Journal of Cannabis Research, used 10 microsatellite markers—variable regions of DNA that can help distinguish related plants—to compare samples purchased from dispensaries and other legal sources in Colorado, California and Washington. The full 2019 study is available open access.

The researchers examined two related questions: whether the commonly used Sativa, Indica and Hybrid categories had a clear genetic basis, and whether samples sold under the same strain name shared a consistent genetic identity.

The results did not support a clear genetic divide among those three retail categories. Statistical analysis identified two broad genetic groups, but they did not correspond to the reported Sativa, Indica and Hybrid proportions assigned to the samples. For example, “Durban Poison,” commonly described as 100 percent Sativa, and “Sour Diesel,” often described as predominantly Sativa, showed sharply different genetic assignments.

The finding is consistent with earlier research indicating that the popular Sativa-Indica distinction only partially reflects cannabis genetic structure. A genome-wide study of marijuana and hemp found a stronger genetic separation between hemp and drug-type cannabis than between the retail categories commonly used for high-THC products. A later comparative study published in 2021 reached a similar conclusion: hemp and drug-type samples separated clearly, while Sativa, Indica and Hybrid samples largely occupied overlapping genetic space.

The 2019 study also found substantial variation among samples carrying the same strain name. Only four of the 30 names showed consistent genetic assignments across all sampled products. That number increased to 11 after one divergent sample was excluded and to 15 after two were excluded. The researchers noted that many of the remaining strains contained outliers or showed no consistent genetic pattern, although limited sample sizes made some comparisons difficult to interpret.

Even labels associated with “clone-only” varieties were not uniformly reliable. All eight clone-only strain names included at least one genetically differentiated sample. “Blue Dream,” for instance, contained several nearly identical samples alongside one clearly divergent sample, while “Girl Scout Cookies” showed relatively little genetic cohesion across the samples tested.

The analysis also identified instances in which samples sold under different names appeared unusually closely related. “Golden Goat” samples were more closely related to “Island Sweet Skunk” than some samples sold under the same “Sour Diesel” name, although the researchers noted that the relationship could reflect reported breeding history. Two samples sold as “Larry OG” and “Tahoe OG” from the same location had matching genotypes, which the researchers considered possible evidence of mislabeling or misidentification—not proof of how the error occurred.

These results do not show that every cannabis product is mislabeled, nor do they establish that a particular name has no value. After divergent samples were removed, many strain groups showed considerable genetic similarity, and some samples appeared to be first-order relatives or closer. The study instead suggests that the marketplace lacks a dependable, standardized system for verifying what a strain name represents.

That distinction matters because genetic identity, plant appearance, cannabinoid content and user experience are not interchangeable. A plant’s chemical profile can also be influenced by growing conditions, harvest practices and storage. Consequently, a Sativa or Indica label should not be treated as a scientifically reliable guarantee of a product’s effects, and this study did not test whether the sampled genetic differences caused particular medical or psychological outcomes.

The researchers concluded that genetic fingerprinting could help producers, regulators and consumers verify plant identity and reduce errors introduced during breeding, propagation, labeling or retail distribution. A larger sampling effort, combined with standardized genetic and chemical profiles, would be needed to determine how widespread these inconsistencies are and to develop a more precise system for identifying cannabis cultivars.